Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004431894 | SCV004916699 | uncertain significance | Inborn genetic diseases | 2024-01-12 | criteria provided, single submitter | clinical testing | The c.329C>T (p.P110L) alteration is located in exon 3 (coding exon 1) of the BMP4 gene. This alteration results from a C to T substitution at nucleotide position 329, causing the proline (P) at amino acid position 110 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005003757 | SCV005629347 | uncertain significance | Microphthalmia with brain and digit anomalies; Orofacial cleft 11 | 2024-05-30 | criteria provided, single submitter | clinical testing |